Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies - EBioMedicine

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies - EBioMedicine

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model - EBioMedicine

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model - EBioMedicine

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination - EBioMedicine

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination - EBioMedicine

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry - The Lancet Rheumatology

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry - The Lancet Rheumatology

Surviving COVID-19: a familiar road to recovery? - The Lancet Respiratory Medicine

Surviving COVID-19: a familiar road to recovery? - The Lancet Respiratory Medicine

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study - The Lancet Respiratory Medicine

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study - The Lancet Respiratory Medicine

Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study - The Lancet Public Health

Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study - The Lancet Public Health